ProblemsShould We Buy a Competitor? › Fintech

Should We Buy a Competitor?
in Fintech

Acquisitions fail on integration far more often than on price, and the integration cost is the number least likely to have been estimated. This page works through it for fintech companies specifically — including an unedited excerpt from a real analysis of a fintech.

The short answer

Acquisitions fail on integration far more often than on price, and the integration cost is the number least likely to have been estimated. What makes this harder for fintech companies is structural: lending fixed the P&L and converts revenue worth a 7x multiple into revenue worth a 2x multiple. Any credible answer therefore has to hold blended take rate and charge-off rate in the same view, which is exactly where most internal analysis stops because the two live in different systems.

The case for buying a competitor is usually built on revenue synergies, which are the least reliable category of benefit and the slowest to arrive. Cost synergies are more predictable, and the honest ones are usually smaller than the model assumes.

The number that decides most outcomes is integration cost — systems, people, customer disruption, and the management attention diverted from the existing business for a year or more. It is routinely omitted because it is hard to estimate and does not appear on either company's accounts.

The disciplined version asks what specifically you get that you could not build or buy more cheaply another way, and what the business looks like if none of the revenue synergies materialise.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ The rationale leans on cross-selling to each other's customers
✓ Integration is described but not costed
✓ The acquisition is partly motivated by the core business having stalled

The move that usually makes it worse. Underwriting the deal on revenue synergies, which typically arrive late, smaller than modelled, or not at all.

Who this is for — and who it is not

It is for you if you run or finance a fintech and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a fintech. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Verrano Pay, a sample company profile used for testing rather than a customer — $84M net revenue, 28,000 merchants, $9.4B of payment volume.

Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile

The move. Convert the $110M lending book into a two-sided marketplace that adds 100k merchants and 3+ capital providers within 36 months while staying inside the $150M warehouse facility

The leak it closes. Plugs value leakage to partner platforms by surfacing competing capital offers inside the Verrano dashboard, reducing merchant incentive to leave the ecosystem when platforms launch competing lending products

The assumption it rests on. Warehouse facility remains available at current terms for at least 24 months — the engine put the probability at 0.75.

What the run committed to
Investment required$2.1M-$4.2M total over 36 months
Expected return18.3×-54.9× on $2.1M-$4.2M investment if marketplace captures 15-45% of $42B TAM at 70% contribution margin
Revenue, year 1$1.9M-$5.8M marketplace revenue
Revenue, year 2$7.7M-$23.1M marketplace revenue
Revenue, year 3$19.2M-$57.6M marketplace revenue
Exit criteriaTerminate marketplace initiative if fewer than 2 capital providers commit by Month 12 OR if 90-day rolling charge-off rate exceeds 7.5% before Month 18; redirect resources to direct-acquisition lending expansion or payments CAC payback improvement

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For fintech companies it works through blended take rate, charge-off rate, contribution margin and CAC by channel, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

How do I value a competitor?

Twice — once standalone, and once for what it is worth specifically to you. The gap between those is the most you can pay and still create value, and it is usually narrower than expected.

Are cost or revenue synergies more reliable?

Cost, substantially. They are within your control and can be scheduled. Revenue synergies depend on customers behaving as modelled, which is the assumption most often wrong.

What is the most common reason acquisitions fail?

Integration consuming more management attention than anyone budgeted, so that both businesses underperform during the period the deal was supposed to be paying back.

Is this different in fintech than in other industries?

Materially, yes. Lending fixed the P&L and converts revenue worth a 7x multiple into revenue worth a 2x multiple — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are blended take rate, charge-off rate, contribution margin, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a fintech?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on blended take rate and charge-off rate. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

Is this what is happening in your business?

Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.

Describe my situation →

Prefer to skip ahead? Go straight to the free diagnostic.